Projects per year
Abstract
Proteolysis targeting chimeras (PROTACs) are catalytic heterobifunctional molecules that can selectively degrade a protein of interest by recruiting a ubiquitin E3 ligase to the target, leading to its ubiquitylation and degradation by the proteasome. Most degraders lie outside the chemical space associated with most membrane-permeable drugs. Although many PROTACs have been described with potent activity in cells, our understanding of the relationship between structure and permeability in these compounds remains limited. Here, we describe a label-free method for assessing the permeability of several VH032-based PROTACs and their components by combining a parallel artificial membrane permeability assay (PAMPA) and a lipophilic permeability efficiency (LPE) metric. Our results show that the combination of these two cell-free membrane permeability assays provides new insight into PROTAC structure–permeability relationships and offers a conceptual framework for predicting the physicochemical properties of PROTACs in order to better inform the design of more permeable and more effective degraders.
Original language | English |
---|---|
Pages (from-to) | 1732-1738 |
Number of pages | 7 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 11 |
Issue number | 9 |
Early online date | 30 Jul 2020 |
DOIs | |
Publication status | Published - 10 Sept 2020 |
Keywords
- Selective degradation
- PAMPA
- LPE
- permeability
- structure-permeability relationships
ASJC Scopus subject areas
- Drug Discovery
- Biochemistry
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Understanding and Improving the Membrane Permeability of VH032-Based PROTACs'. Together they form a unique fingerprint.Projects
- 1 Finished